espite their ubiquitous use, both frame-based and frameless stereotactic biopsies rely on preoperative images with intraoperative anatomical or fiducial registration to reach deep brain targets based on precalculated measurements in 3D space. 1, 3, 6, 8, 14, 15, 23 The primary limitations of these approaches are the inability to account for the shift of intracranial structures (reduces accuracy of the biopsy at the target), the inability to adapt to vital structures along the needle trajectory in real-time, and the lack of intraoperative imaging confirmation of the accuracy of the biopsy target. 5, 7, 13, 22 Moreover, miscalculations or technical misalignment of hardware during biopsy can result in intraoperative morbidity. 6, 10 Recent data indicate that the diagnostic accuracy of stereotaxy using conventional preoperative neuronavigation may be lower than previously reported (accuracy range 51%-91%). 3, 4, 8 To overcome these limitations, technology has been developed that now permits the integration of intraoperative MRI (iMRI) with frameless stereotaxy. The resolution and real-time feedback of this iMRI technology has been demonstrated in phantom experiments, 12,18 nonhuman primate studies, 16,17 drug infusion cannula placement, 2 and placement of deep brain stimulator leads. 9, 11, 20, 21 Application of this technology to stereotactic brain biopsy could eliminate misdiagnosis secondary to faulty targeting, provide realtime adaptability for needle trajectory, confirm accurate biopsy cannula position, and provide immediate imaging of complications. To determine the feasibility, accuracy, and safety of real-time MRI-guided brain biopsy, we analyzed the results in consecutive brain biopsy cases using this paradigm.
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biopsy Platform
The ClearPoint System (MRI Interventions Inc.) is composed of an integrated head fixation frame, a disposable SmartFrame scalp-mounted guide, a dedicated computer workstation for surgical planning, and an MR-compatible in-room computer monitor (Fig. 1 ). An MR-compatible cannula, including a ceramic guide stylet (MRI Interventions Inc.) and a biopsy needle (Ad-Tech) were used for targeting and tissue collection.
imaging system and operating room
An open "single-doughnut" system with a 1.5-T MR unit (Siemens AG) was used in all cases. The ClearPoint Workstation uses proprietary software (ClearPoint Imaging Software version 1.51) to communicate with the MRI console and permits the surgeon to make targeting decisions and adjustments in the operating room. The iMRI suite is a fully functional operating room with the same standards of airflow and sterility applied for regular operating suites at our institution. The suite is equipped with an MR-compatible anesthesia machine and monitoring devices. Magnetic resonance-compatible surgical instruments were used in all cases.
histopathological analysis
Core biopsy samples were sent for permanent tissue pathology evaluation. Routine and immunohistochemical studies were performed as indicated.
targeting accuracy data and statistical analysis
The accuracy of biopsy needle insertion in relation to the intended target was quantified in patients by measuring the radial error and depth error, as well as by calculating the absolute tip error. The measurements needed to calculate these errors, target location, and tip location were obtained from images acquired during real-time MRI-guided biopsy. The intended target location was selected on initial images prior to placement of the biopsy needle. Location of the needle tip was manually selected by identifying the center-most distal tip of the needle on MRI sequences obtained prior to tissue harvest. The stereotactic software automatically reported vector distances between the intended target site and the actual position of the biopsy needle tip to give target depth, radial error, and depth error for each patient in 3D space (Fig. 2) , and the primary author and senior author reviewed all data for analysis. The primary measure for error reporting was the absolute tip error, which was the calculated distance from the tip of the biopsy needle to the intended target. Error measurements were tested for linear correlation by calculating the Pearson product-moment correlation coefficient. A coefficient of 1 is considered a total positive correlation, 0 is no correlation, and -1 is a total negative correlation. 19 
technique
Prior to surgery, the preoperative MRI sequences are loaded into the computer workstation, and the cannula entry point, trajectory, and target for biopsy are selected. After general anesthesia is induced, hair in the region of the entry point is shaved to accommodate the 4 × 4-cm localizer grid, which is placed once the patient is positioned in the MR facility. Patients are then taken into the MR facility and positioned in an MR-compatible head fixation frame with 4 points of fixation. Three patients in this study were supine and 2 were prone. Head rotation/ flexion/extension was adjusted in each case to optimize the trajectory of the biopsy needle relative to the surgical field and space limitations of the bore of the magnet. A T1-weighted MR image is then obtained, and the anterior and posterior commissures are identified to orient the software system to the head position. After this initial image, the surgical site is prepared and draped using a specialized draping system compatible with multiple transitions into and out of the bore of the magnet.
A 4 × 4-cm localizer grid ( Fig. 1 ) is then applied to the scalp, overlying the predetermined incision site and skull entry point. A T1-weighted MR image is obtained either without or with a half dose of gadolinium based on enhancing properties of the lesion (a half dose of gadolinium is used in enhancing lesions so that another dose of gadolinium can be used later if needed). Coordinates of the preselected entry point relative to the localizer grid are then determined using the integrated software at a computer workstation, and the final entry point, trajectory, and target points are confirmed. The localizer grids are then removed, and an MR-compatible biopsy frame is attached percutaneously (using 1.62-mm screws) to the patient's skull, centered over the entry point as guided by the localizer grids (Fig. 1) .
A series of T1-weighted MR images focused on the biopsy frame and target lesion are then used to fine-tune the trajectory of the guide cannula mounted on the frame. The software detects the position of the cannula relative to the base and target that were previously scanned and defined. This will provide a projection of where the cannula is currently aimed and give the user instructions to grossly align the cannula to the target. Between each scan, the biopsy system is fine-tuned as guided by the navigation system software. Specifically, a series of images are taken at oblique coronal and sagittal planes along the trajectory of the cannula (with isocentering of the scan parameters to optimize distortion-free representation). These data are overlaid, and a best-fit line is projected from the cannula to the target in MR space.
Once the trajectory is finalized, a percutaneous twistdrill hole is made in the skull, and a ceramic guide cannula (1.5-mm diameter) is inserted along the preselected trajectory to a depth 5 mm from the surface of the target lesion. Real-time T1-weighted MRI during cannula placement is employed to ensure accuracy of the cannula trajectory and safety of the pathway to the target. The ceramic stylet (1.5-mm diameter) is removed once the trajectory is confirmed. The biopsy needle (2.1 mm) is then inserted along the same trajectory to the appropriate depth within the lesion, and after confirming the final location of the biopsy needle with MRI, multiple core biopsy samples are harvested. Tissue cores are harvested using an MRIcompatible, side-cutting biopsy needle (Ad-Tech) and sent for permanent section.
After completing the biopsy core sampling, the biopsy needle is maintained in place for 5 minutes to assist with hemostasis and is then removed. Final MRI specific to the imaging properties of the lesion is then performed to evaluate for complications and identify any tissue defect and/ or needle tract, which secondarily verifies accuracy of the biopsy site. The cannula and guidance frame are then detached from the skull, and the percutaneous stab incisions are closed with a cutaneous adhesive agent (Dermabond, Ethicon).
results

Patients
Five patients (4 males, 1 female) were included in the study. Mean age at surgery was 45.8 years (range 29-60 years). Patient characteristics are included in Table 1 .
intraoperative imaging Findings
Intraoperatively, lesions varied in size and radiographic appearance based on contrast enhancement on T1-weighted imaging or increased FLAIR/T2 signal intensity ( Table  1 ). The ceramic stylet was clearly visible during placement as a hypointense signal on T1-weighted imaging. Real-time imaging of the ceramic stylet confirmed an accurate trajectory and depth in all cases, and no targeting adjustments were required prior to placement of the biopsy needle. The biopsy needle was noted to have a larger hypointense signal diameter on T1-weighted sequences. Postbiopsy scans revealed T1-and T2-weighted hypointense signal changes within the lesion consistent with a defect created by tissue harvest.
system accuracy
Intraoperative MRI confirmed accurate biopsy needle placement at the target in all patients. Mean target depth was 71.3 mm (range 60.4-80.4 mm), mean radial error was 1.3 ± 1.1 mm (mean ± standard deviation), and mean depth error was 0.7 ± 0.3 mm. The mean absolute tip error (Table 2 ). Mean operative time was 114 ± 42.8 minutes. Biopsied tissue provided a definitive diagnosis in all cases ( Table 1 ). All biopsy needles were placed with a single brain penetration. No correlation was found between the target depth and the absolute tip error (calculated Pearson product-moment correlation coefficient, r = 0.22).
complications
There were no surgical complications in any of the patients. No evidence of a bleed was noted on intraoperative imaging.
illustrated cases case 1
A 38-year-old female with a history of breast cancer presented with new-onset seizures (Table 1) . Magnetic resonance imaging revealed a left posterior thalamic enhancing mass (Fig. 3) . Given the depth of the lesion and its proximity to the brainstem and adjacent white fiber tracts, real-time iMRI-guided biopsy was performed to obtain tissue diagnosis before radiation therapy. Intraoperative imaging was performed to determine the trajectory to the target and biopsy planning. Using real-time T1-weighted MRI, we placed the biopsy needle within the enhancing lesion. Magnetic resonance imaging confirmed the presence of the biopsy needle tip in the lesion, and a biopsy was performed. Histological diagnosis revealed metastatic breast carcinoma.
case 2
A 29-year-old male (Table 1) presented with a generalized tonic-clonic seizure. An abnormal focus of hyperintensity on T2-weighted MRI was demonstrated within the left inferior frontal lobe that did not contrast enhance (Fig.  4) . Given the small size of the lesion and its proximity to the anterior cerebral artery, the lesion was approached for biopsy via a real-time iMRI-guided approach. Intraoperative imaging was performed to determine a trajectory, which avoided the lateral ventricle and corpus callosum. Using real-time T1-weighted MRI, we placed the ceramic cannula 5 mm above the target to confirm the trajectory. Magnetic resonance imaging confirmed the presence of the biopsy needle tip at the target, and a biopsy was performed. Histological diagnosis revealed dysembryoplastic neuroepithelial tumor (DNET). Intraoperative T2-weighted MRI confirmed accurate targeting, as evidenced by a cavity at the center of the lesion.
case 3
A 60-year-old male presented with a recurrent right occipital lobe glioblastoma multiforme (GBM). The patient was symptomatic with gait imbalance, a visual field cut, headaches, and emesis. Magnetic resonance imaging revealed possible tumor recurrence or pseudo-progression. It also revealed increased periventricular contrast enhancement along the anterior margin of the resection cavity that extended into the splenium of the corpus callosum. Magnetic resonance perfusion imaging demonstrated a small area of hyperperfusion within the lesion. An iMRI-guided biopsy was preferred over conventional stereotactic biopsy to target the small focus of hyperperfusion, which had a unique enhancement profile compared with surrounding tissues. Intraoperative MR images confirmed accurate placement of the biopsy cannula in the target area of the lesion (captured with T1-weighted images with contrast and correlated with the perfusion imaging). Multiple cores were harvested and sent for permanent section, which confirmed a diagnosis of recurrent GBM.
case 4
A 52-year-old male with a known history of high-grade glioma presented with possible tumor recurrence. Magnetic resonance imaging revealed a small left temporal enhancing nodule adjacent to the previous resection cavity but close to the brainstem and surrounding critical basal cistern vasculature. An iMRI-guided biopsy was preferred over conventional stereotactic biopsy for accurate target- ing of the small focus of enhancement in this eloquent region. Intraoperative MR images to confirm accurate placement of the cannula in the target lesion were captured using T1-weighted sequences with contrast. Multiple cores were harvested and sent for pathology and confirmed a diagnosis of GBM.
case 5
A 50-year-old male with a known history of high-grade glioma presented with aphasia and imaging evidence of possible tumor recurrence. An iMRI-guided biopsy was selected over conventional stereotactic biopsy for the most accurate targeting of the small focus of enhancement in the insular region. Intraoperative images to confirm accurate placement of the cannula in the target lesion were captured using T1-weighted sequences with contrast. Multiple cores were harvested and sent for pathology and confirmed a diagnosis of GBM.
discussion
Previous work
Recently, this frameless stereotactic guidance system has been successfully used for accurate real-time MRIguided placement of deep brain stimulator leads, 9,20,21 laser diode applicators, 24 and convection-enhanced-delivery infusion cannulae. 16, 17 Given the backdrop of applications, this frameless stereotactic guidance system offers an opportunity to perform real-time MRI-guided biopsy with advantages over currently available stereotactic biopsy techniques. Specifically, this platform can be used via a percutaneous approach, provides real-time confirmation of trajectory or target accuracy, and is compatible with high-field magnets that provide for excellent resolution. Because real-time imaging is performed during cannula and/or biopsy needle placement, intraoperative trajectory and/or target adjustments are possible. Here, we assessed the feasibility, accuracy, and safety of this real-time MRI-guided brain biopsy platform in 5 consecutive brain biopsy cases.
current study
Patients
While this technology has potential advantages for use in all biopsies, the patients in the current report were selected to undergo iMRI biopsy for brain lesions or for targets that were small and/or located in anatomical regions near critical vascular and/or anatomical structures. Consequently, these cases illustrate the safety and accuracy of this technique, as well as underscore the potential advantage for sampling lesions in eloquent anatomical locations or areas otherwise potentially difficult to reliably target (Table 1 ). The real-time imaging feedback us- ing this technique permits on-the-fly targeting adjustments to avoid immediately adjacent vasculature and/or eloquent anatomical structures. Magnetic resonance imaging-confirmed targeting in this manner obviates unnecessary tissue sampling, including frozen section.
Accuracy
Use of this real-time MRI stereotactic technique and platform allows for reliable and accurate biopsies. Phantom and cadaveric studies using this system for deep brain stimulator lead placement have reported a mean radial error of 0.5 mm. 9 Clinical application of similar technology in 29 patients with Parkinson disease who had undergone real-time MRI-guided placement of 53 deep brain stimulation electrodes resulted in a mean radial error of 1.2 mm and a mean absolute tip error of 2.2 mm. 21 Consistent with these findings, we found a mean radial error of 1.3 mm for the final biopsy needle position and a mean absolute tip error of 1.5 mm (Table 2) . These error measurements support the use of our technique for the accurate placement of biopsy needles with a high degree of precision.
Effectiveness
This real-time MRI-based biopsy technique was effective according to intraoperative MRI confirmation of biopsy needle placement within the lesion, MRI evidence of target sampling, and confirmation of diagnostic tissue on pathological analysis. Because of the accuracy of this biopsy technique, all biopsy samples were taken at the desired target. These resulted in a 100% diagnostic sampling rate. Furthermore, this skull-mounted MRI guidance technique permitted confirmation and adjustment of the cannula trajectory before placement of the biopsy needle into the brain and/or lesion. While it was not necessary to readjust the trajectory and/or needle depth in any case, on-the-fly adjustments of the cannula trajectory or needle depth could be made, if needed, based on the real-time MRI feedback (Figs. 3 and 4) .
Feasibility
This technique is easily adapted and employed. Average operative time in our cases was 114 minutes. The operative time required for the technique decreased as experience increased. Intraoperative time for individual cases can vary according to the radiographic features of the lesion and the trajectory chosen. Lesion properties can influence the MR sequences selected during planning and the number of targeting adjustments made intraoperatively. The number of scans required to reach the target ranged from 3 to 5 scans per patient in our study. Although pathological diagnosis for unusual lesions may be ambiguous, with MRI confirmation of an accurate biopsy, concern for missing a lesion is eliminated. This renders the frozen section histological analysis unnecessary.
Safety and Clinical Features
Real-time MRI during stereotactic brain biopsy using this platform is safe and is approved for 1.5-T and compatible with 3.0-T magnets. No patients sustained a clinical or radiographic complication. Cosmetically, the technique described represents a potential improvement over other biopsy platforms in that there is no linear incision requiring sutures or staples. We found that the stab incisions for the mounting screws and twist drill heal quickly with minimal evidence of scarring, less even than that for pins used with the Mayfield head clamp or halo vests. The percutaneous aspect allowed attachment of the frame to the forehead in front of the hairline to optimize the trajectory to the lesion in the patient in Case 2 (Table 1) , avoiding neural structures including the ventricle and corpus callosum. Once the targeting is completed, a variety of options beyond biopsy, such as convection-enhanced-delivery infusion cannulae or laser ablation technology, could be applied via the platform with probably similar targeting accuracy and capacity for real-time monitoring of the selected treatment. Although such treatment options are beyond the scope of this paper, they underscore the flexibility of this percutaneous stereotactic iMRI-guided platform.
conclusions
Using iMRI real-time biopsy technology offers several advantages. First, it permits standardization of stereotactic MRI-guided biopsies through a percutaneous approach. Second, it allows for safe and precise targeting of brain lesions for biopsy in high-field MR scanners. Third, the defined real-time accuracy assessment of this system can be used in broader scientific applications, including the investigation of intratumoral tissue heterogeneity and correlation with radiographic tumor features.
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